Ureaplasma during pregnancy: risks for mother and child

Ureaplasma is an opportunistic pathogen that can be present in the urogenital tract without causing any obvious symptoms. However, during pregnancy, even these microorganisms require increased attention, as immune system changes can contribute to their activation. Monitoring the microflora during pregnancy is important for maintaining a woman’s health and reducing potential risks to the fetus.

What is Ureaplasma species?

Ureaplasma species are small microorganisms from the mycoplasma group that can colonize the mucous membranes of the genitourinary system. Their unique feature is their ability to break down urea and exist on the surface of epithelial cells without penetrating deep into the tissue.

The most common species are Ureaplasma urealyticum and Ureaplasma parvum, which differ in their properties and potential impact on the body. Normally, a small number of these microorganisms is not considered pathological. However, with weakened immunity or changes in the microflora, including during pregnancy, ureaplasma can actively multiply and cause inflammatory processes that require monitoring or treatment. Therefore, in clinical practice, not only the presence of ureaplasma itself is important, but also its quantity, as well as any accompanying inflammatory changes.

Routes of Ureaplasma Transmission

Ureaplasma species are transmitted primarily through close contact with mucous membranes. The main routes of transmission of the microorganism are:

1. Sexual transmission. The most common mode of transmission is through unprotected contact.
2. Vertical transmission. From mother to child during pregnancy or childbirth.
3. Contact-household transmission. Unlikely, but theoretically possible with close contact and poor hygiene.

The risk of transmission increases in the presence of inflammatory processes, weakened immunity, and the absence of barrier contraception.

Is ureaplasma dangerous during pregnancy?

The presence of Ureaplasma species during pregnancy does not always indicate illness or a threat. It can often be present without symptoms and not affect the course of pregnancy. However, under certain conditions, the microorganism can become active and cause inflammation.

The risk increases if the number of ureaplasmas increases, the microflora balance is disrupted, or the immune system is weakened. In such situations, infectious complications may develop, requiring medical observation and, if necessary, treatment.

Therefore, the clinical significance is not the detection of ureaplasma itself, but its concentration, the presence of symptoms, and the woman’s overall condition.

Risks for pregnant women

With active reproduction of Ureaplasma species, a pregnant woman may develop an inflammatory process in the genitourinary system. This increases the risk of complications and requires medical supervision.

Possible risks:

• inflammatory diseases – cervicitis, urethritis, vaginitis;
• ascending infection – spread of inflammation to the uterus and fetal membranes;
• threat of miscarriage, especially in the early stages;
• preterm labor;
• postpartum complications (inflammatory processes).

The severity of the risks depends on the amount of pathogen, the state of the immune system, and the presence of concomitant infections, so it is important to undergo examination promptly and follow the doctor’s recommendations.

Risks to the fetus and newborn

With an active Ureaplasma species infection, there is a risk of transmission from mother to child, which can affect the course of pregnancy and the condition of the newborn. The degree of risk depends on the severity of the infection and the gestational age.

Possible risks to the fetus:

• intrauterine infection;
• developmental impairment due to a prolonged inflammatory process;
• low birth weight;
• preterm birth.

Possible consequences of Ureaplasma species infection for the newborn:

• respiratory tract infections (including pneumonia);
• inflammatory processes (conjunctivitis, mucosal lesions);
• weakened immune response in the first weeks of life.

It is important to understand that such complications do not always occur, however, if an infection is detected during pregnancy, monitoring and, if necessary, treatment are required to reduce possible risks.

Symptoms of ureaplasmosis during pregnancy

Ureaplasmosis during pregnancy is often asymptomatic, especially in the early stages. However, if the infection becomes active, it can cause Signs of inflammation in the genitourinary system may appear:

• unusual vaginal discharge—mucous or foul-smelling;
• burning or discomfort in the genital area;
• pain or stinging during urination;
• pulling pain in the lower abdomen;
• discomfort during sexual intercourse.

Symptoms can be subtle or nonspecific, so they can easily be confused with other conditions. This is why regular checkups are important during pregnancy, even in the absence of complaints.

Diagnosis of Ureaplasma

Detection of Ureaplasma species requires laboratory testing, as the infection is often asymptomatic. Accurate diagnosis helps assess the risks to the mother and fetus and determine the need for treatment.

Main diagnostic methods:

1. PCR (polymerase chain reaction). The most sensitive method, it allows detection of pathogen DNA even at low concentrations.
2. Bacteriological culture. Allows determination of the number of microorganisms and their sensitivity to antibiotics.
3. Microflora analysis. Allows assessment of the urogenital microflora and identification of concomitant infections.

For reliable results, samples are usually taken from the vagina, cervix, or urethra. You can get tested for Ureaplasma species at the Nikolab laboratory.

Treatment of Ureaplasma during Pregnancy

Treatment for ureaplasmosis during pregnancy is prescribed only if necessary and after assessing all risks. If the microorganism concentration is low and there are no symptoms, the doctor may limit observation to observation.

Basic principles of therapy:

1. Selecting safe antibiotics. Drugs approved for use during pregnancy, such as macrolides, are used.
2. Compliance with the treatment course. It is important to complete the full course to reduce the risk of relapse.
3. Treatment of both partners to prevent reinfection.
4. Post-treatment monitoring. Repeat testing to confirm the effectiveness of therapy.

Ureaplasma infection during pregnancy does not always cause disease, but it requires attention and monitoring. Proper pregnancy management during infection with this microorganism can reduce the risk of complications and ensure the health of mother and child.